Nurse Practitioner · Hershey, PA
NPI
1164823308
Since 2014
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
500 University Dr
Hershey, PA, 17033
Phone (717) 531-8395
Groups this clinician bills Medicare through
Medicare paid, 2024
$12K
213 services
Medicare patients, 2024
111
Average age 71
Drug cost, 2024
$2.1M
3,354 prescriptions
Company payments, 2025
$364
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elaine J McGinty was code 99214 (office e&m - established), 90 times for 61 patients. In total Elaine J McGinty billed 213 services in 9 codes, and Medicare paid $12K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-02-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 90 | 61 | $57.27 | $5,155 |
| 99213 Office E&M - Established | Office | 79 | 59 | $40.34 | $3,187 |
| 99204 Office E&M - New | Office | 18 | 18 | $77.66 | $1,398 |
By year: 2022 $15K for 252 services; 2023 $10K for 205 services; 2024 $12K for 213 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elaine J McGinty prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 355 prescriptions and refills. In total Elaine J McGinty wrote 3,354 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 355 | 577 | 79 | $602K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 337 | 672 | 106 | $43K |
| Novolog Flexpen Insulin Aspart | 236 | 360 | 74 | $54K |
| Jardiance Empagliflozin | 183 | 432 | 59 | $249K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 155 | 433 | 69 | $22K |
| Metformin Hcl Generic | 153 | 399 | 43 | $1,177 |
| Metformin Hcl Er Metformin Hcl | 138 | 361 | 47 | $3,177 |
| Trulicity Dulaglutide | 114 | 187 | 31 | $181K |
| Tresiba Flextouch U-200 Insulin Degludec | 109 | 209 | 25 | $155K |
| Ozempic Semaglutide | 101 | 171 | 24 | $160K |
| Humalog Kwikpen U-100 Insulin Lispro | 91 | 148 | 24 | $32K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 86 | 160 | 27 | $41K |
| Tresiba Flextouch U-100 Insulin Degludec | 85 | 163 | 24 | $49K |
| Ultra-Fine Mini Pen Needle Pen Needle, Diabetic | 60 | 159 | 24 | $9,652 |
| Glimepiride Generic | 57 | 140 | 18 | $513 |
Brand drugs: 2,328 claims; generic drugs: 568 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elaine J McGinty $364 ($364 in general payments such as food, travel and fees) from 3 companies. The largest payer was Tandem Diabetes Care, Inc. with $165.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.